We are delighted to announce jointly with FARE that ATANIS has won the Innovation Award Diagnostic Challenge, which comes with a $ 2 million grant to be used in furthering commercialization efforts of FAST-PASE®. More information in the attached…

ATANIS Biotech, a company specializing in advanced allergy diagnostics, has successfully completed an oversubscribed funding round, led by Spectrum Moonshot Fund and supported by experienced investors in the allergy field. The funds will be used to…

ATANIS has successfully completed a significant capital increase, moved to a new location and has hired new key personnel. iXLife a venture capital fund from France co-led the financing round with US-based AllerFund, the first and only venture…

ATANIS has participated at the Bernese Business Creation Competition “Stage-Up” organized by the Entrepreneurship Center of the University of Bern, Switzerland. After six months of hard work and three rounds of in-depth evaluation, 5 teams out of…

ATANIS has been incorporated by the four co-founders Mrs. Noemi Zbären (M. Sc. University of Bern), Prof. em. Dr. med. Jean-Pierre Kinet (Harvard Medical School), Prof. Dr. phil. nat. Thomas Kaufmann (University of Bern) and Prof. Dr. phil. nat.